Effects of bright incandescent light on seasonal and nonseasonal major depressive disorder

Psychiatry Research
B I YerevanianM Bray

Abstract

Previous research has indicated that exposure to bright fluorescent light can benefit clinically depressed individuals. The present study, a 1- to 2-week open trial of bright (greater than or equal to 2,000 lux) incandescent light with seasonal (fall/winter) and nonseasonal depressives, produced a therapeutic effect on seasonal depression, as measured by three criteria for recovery: final score on the Hamilton Rating Scale for Depression (HRSD) less than 10; final HRSD score less than or equal to 50% of pretreatment HRSD score; no longer meets DSM-III criteria for major depressive disorder. Phototherapy was not effective in the nonseasonal patients, whose functioning was more impaired than that of the seasonal subjects even before the trial. No adverse effects were observed in any patient.

References

Apr 1, 1979·Photochemistry and Photobiology·W T HamA M Clarke
Feb 1, 1985·The American Journal of Psychiatry·N E RosenthalT A Wehr
Dec 1, 1967·The British Journal of Social and Clinical Psychology·M Hamilton
Jan 7, 1983·Science·R PrzewłockiL D Reid
Oct 1, 1983·Psychiatry Research·D F KripkeD Janowsky
Jun 1, 1983·Physiology & Behavior·K HonmaJ Aschoff
May 1, 1980·Health Physics·J A Zuclich
Nov 1, 1982·The American Journal of Psychiatry·A J LewyT A Wehr
Dec 12, 1980·Science·A J LewyS P Markey
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON

❮ Previous
Next ❯

Citations

Jan 1, 1997·European Archives of Psychiatry and Clinical Neuroscience·M J MüllerE Holsboer-Trachsler
Aug 1, 1991·Biological Psychiatry·A MackertB Müller-Oerlinghausen
Jan 15, 1992·Biological Psychiatry·D F KripkeJ C Gillin
Oct 15, 1992·Biological Psychiatry·J L AndersonJ J Schildkraut
Mar 1, 1989·Journal of Affective Disorders·E SzádóczkyE Moussong-Kovács
May 1, 1990·Journal of Affective Disorders·H P VolzB Müller-Oerlinghausen
Jun 1, 1990·Journal of Affective Disorders·W van den BurgD G Beersma
Feb 1, 1990·Journal of Affective Disorders·D Stinson, C Thompson
Aug 1, 1991·Journal of Affective Disorders·E SzádóczkyE Moussong-Kovács
Oct 1, 1991·Journal of Affective Disorders·Y MeestersR H van den Hoofdakker
Apr 1, 1992·Journal of Affective Disorders·R W LamR A Remick
Jul 1, 1993·Journal of Affective Disorders·Y MeestersR H van den Hoofdakker
Sep 1, 1993·Journal of Affective Disorders·Y MeestersR H van den Hoofdakker
Apr 1, 1991·Psychiatry Research·P GrawW Pöldinger
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·H W Lahmeyer
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·J Seggie
Jan 1, 1989·Progress in Neuro-psychopharmacology & Biological Psychiatry·J SeggieP Grof
Jan 1, 1990·Progress in Neuro-psychopharmacology & Biological Psychiatry·K T StewartG C Brainard
Jul 21, 1998·Journal of Affective Disorders·L B Cooke, C Thompson
Jun 1, 1997·Journal of Affective Disorders·E M TamA P Zis
May 1, 1995·Acta Psychiatrica Scandinavica·B E ThalénL Wetterberg
Sep 9, 1996·Journal of Affective Disorders·K M Beauchemin, P Hays
Dec 5, 1997·Journal of Affective Disorders·T M LeeC C Chan
May 1, 1990·Comprehensive Psychiatry·D M WhiteD L Wesche
Jun 24, 2006·Journal of Affective Disorders·Michael F Wesner, Josephine Tan
Aug 30, 2005·Issues in Mental Health Nursing·Geoffry W McEnany, Kathryn A Lee
Jan 1, 1994·Journal of Biological Rhythms·R H Van den Hoofdakker
Jan 1, 1988·Journal of Biological Rhythms·N E RosenthalT A Wehr
Apr 24, 2004·The Cochrane Database of Systematic Reviews·A TuunainenT Endo
Sep 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·C ThompsonE A King
Oct 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·N TakeiR Murray
Dec 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·C P Lucas
Mar 1, 1989·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·R W LamJ C Gillin
Jan 1, 1995·European Archives of Psychiatry and Clinical Neuroscience·B E ThalénL Wetterberg
Jun 3, 1999·Acta Psychiatrica Scandinavica·T M Lee, C C Chan
Apr 16, 2002·BMC Dermatology·Thilo GambichlerKlaus Hoffmann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.